BRPI0407421A -
Combination therapy for the treatment of immunoinflammatory disorders
- Google Patents
Combination therapy for the treatment of immunoinflammatory disorders
Info
Publication number
BRPI0407421A
BRPI0407421ABR0407421-1ABRPI0407421ABRPI0407421ABR PI0407421 ABRPI0407421 ABR PI0407421ABR PI0407421 ABRPI0407421 ABR PI0407421ABR PI0407421 ABRPI0407421 ABR PI0407421A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Combinatorx IncfiledCriticalCombinatorx Inc
Priority claimed from PCT/US2004/004077external-prioritypatent/WO2004073614A2/en
Publication of BRPI0407421ApublicationCriticalpatent/BRPI0407421A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
"TERAPIA COMBINADA PARA O TRATAMENTO DE DISTúRBIOS IMUNOINFLAMATóRIOS". A invenção refere-se a um método para tratar um paciente com diagnóstico de um distúrbio imunoinflamatório, ou com risco de desenvolver o mesmo, administrando-se um imunossupressor não-esteróide dependente de imunofilina (NsIDI) e um intensificador de NSIDI (NsIDIE) ou análogo ou metabólito do mesmo ao paciente. A invenção também refere-se a uma composição farmacêutica contendo um NsIDI e um NsIDIE ou análogo ou metabólíto do mesmo para o tratamento ou a prevenção de um distúrbio imunoinflamatório."COMBINED THERAPY FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS". The invention relates to a method of treating a patient diagnosed with or at risk of developing an immunoinflammatory disorder by administering an immunophilin-dependent non-steroidal immunosuppressant (NsIDI) and an NSIDI enhancer (NsIDIE) or analog or metabolite to the patient. The invention also relates to a pharmaceutical composition containing an NsIDI and an NsIDIE or analog or metabolite thereof for treating or preventing an immunoinflammatory disorder.
BR0407421-1A2003-02-142004-02-12
Combination therapy for the treatment of immunoinflammatory disorders
BRPI0407421A
(en)
Processes for treating toxicities associated with administering a therapeutic agent to a mammal, for treating toxicities associated with a mammal's exposure to radiation therapy, for treating neuro- or nephrodisturbs in a human, and for treating disorders and clinical symptoms associated with type i or type ii diabetes in a human
Use of levetiracetam, pharmaceutical composition, use of a pharmaceutical composition and methods to treat a patient administered with an amount of at least one compound and a disease and to selectively potentiate the therapeutic effect of a compound